<DOC>
	<DOCNO>NCT00832520</DOCNO>
	<brief_summary>The purpose study find remeron , also call mirtazapine , help prevent weight loss treatment cancer . Remeron currently use treat depression approve Food Drug Administration use treat weight loss .</brief_summary>
	<brief_title>Phase II Study Remeron Cancer Patients Losing More Than 10 % Their Body Weight</brief_title>
	<detailed_description>Weight loss cancer patient result inadequate intake absorption nutrient and/or tumor-induced weight loss due metabolic change tumor create body ( 1 ) . Inadequate intake result starvation state simply result eat less due depression , nausea/vomiting , feeling fullness , taste change ( 2 ) . Though intentional weight loss cause symptom explain reversed increase intake nutrient . Unintentional weight loss induce tumor cause multiple physiological factor increase catabolism muscle fat increase nutrient intake alone may reverse weight loss . Unintentional weight loss predict poor prognosis cancer patient likely due decrease dos treatment ( 3-5 ) . Usual care weight loss cancer patient varies among practitioner include nutrition counseling register dietitian practitioner . Treatment vary counseling patient increase intake nutrient dense food prescribe medication order improve appetite mood , decrease feeling fullness , control nausea/vomiting , etc . ( 6 ) . However , intervention always work . For varied reason patient able improve oral intake food item patient tumor induce weight loss increase oral intake improve metabolic change . Anti-depressant medication weight related side effect ( 7-9 ) . Mirtazapine show side effect increase appetite increased weight cancer subject study use depression nausea . ( 10-13 ) . These result appear range change appetite change see metabolic process change cytokine system reduce inflammation see cachectic patient . Therefore , use mirtazapine cancer patient even without depression may help stop unwanted weight loss increase survival allow patient complete prescribe treatment .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>1 . All patient , 18 year age old , advanced cancer eligible . 2 . Patients must lose 10 % last 6 month 3 . Patients must life expectancy least 12 week . 4 . Patients must Zubrod performance status 03 . 5 . Patients must sign informed consent . 1 . Patients symptomatic brain metastasis exclude study . 2 . Pregnant woman nurse mother eligible trial . Patients child bear potential must use adequate contraception . 3 . Patients severe medical problem uncontrolled diabetes mellitus cardiovascular disease active infection eligible trial . 4 . Patients head neck cancer GI cancer functional problem limit food intake absorption nutrient partial complete bowel obstruction , patient skin cancer ( except melanoma ) eligible 5 . Patients lose weight voluntary diet . 6 . Patients already take appetite stimulant antidepressant , except SSRI take morning . 7 . Patients surgery last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Advanced cancer</keyword>
	<keyword>weight loss</keyword>
	<keyword>Remeron</keyword>
	<keyword>body weight</keyword>
</DOC>